Clinical Diagnosis and Treatment of Thrombocytopenia-Inducing Diseases

A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".

Deadline for manuscript submissions: closed (30 November 2024) | Viewed by 3188

Special Issue Editor


E-Mail Website
Guest Editor
University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA
Interests: α-synuclein; platelets; thrombocytopenia; alloimmunization; hematopoiesis
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Thrombocytopenia represents a not infrequent finding in patients presenting to hospitals emergency services. Likewise, loss of platelets not only due to disease processes but also as a result of therapies needed to treat diseases are common in clinical settings. Indeed, etiologies that affect the bone marrow’s capacity to replenish blood elements such as malignancies that are either begin or metastasize to the marrow, and even those in which immune system dysregulation leads to antibody formation that either directly or indirectly affect platelets, can be considered as primary issues eliciting different degrees of thrombocytopenia. On the other hand, iatrogenic causes such as medications and physiologic processes such as acute bleeding, infections, and mechanical damage, as in the use of medical devices that consume or impair platelets, can equally drive thrombocytopenia. With so many new developments to address thrombocytopenias being developed that include the development of immunomodulators such as monoclonal antibody therapies, it is becoming more clear that some of these thrombocytopenia-eliciting etiologies can be better treated. Thus, the aim of this Special Issue is to become a forum to showcase novel research from basic science to clinical and translational work encompassing thrombocytopenic presentations. Original reports and reviews are welcome. Case reports or case series may be considered in the context of a thorough review of the relevant literature.

Dr. Robert W. Maitta
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • thrombocytopenia
  • antibody
  • malignancy
  • anemia
  • immune dysregulation
  • antibiotics
  • iatrogenic

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

24 pages, 1310 KiB  
Review
Thrombocytopenia in Sepsis
by Alireza Setarehaseman, Abbas Mohammadi and Robert W. Maitta
Life 2025, 15(2), 274; https://doi.org/10.3390/life15020274 - 11 Feb 2025
Cited by 4 | Viewed by 2793
Abstract
Platelets, traditionally known for their role in hemostasis, have emerged as key players in immune response and inflammation. Sepsis, a life-threatening condition characterized by systemic inflammation, often presents with thrombocytopenia, which at times, can be significant. Platelets contribute to the inflammatory response by [...] Read more.
Platelets, traditionally known for their role in hemostasis, have emerged as key players in immune response and inflammation. Sepsis, a life-threatening condition characterized by systemic inflammation, often presents with thrombocytopenia, which at times, can be significant. Platelets contribute to the inflammatory response by interacting with leukocytes, endothelial cells, and the innate immune system. However, excessive platelet activation and consumption can lead to thrombocytopenia and exacerbate the severity of sepsis. Understanding the multifaceted roles of platelets in sepsis is crucial for developing effective therapeutic strategies. Targeting platelet-mediated inflammatory responses and promoting platelet production may offer potential avenues for improving outcomes in septic patients with thrombocytopenia. Future research should focus on elucidating the mechanisms underlying platelet dysfunction in sepsis and exploring novel therapeutic approaches to optimize platelet function and mitigate inflammation. This review explores the intricate relationship between platelets, inflammation, and thrombosis in the context of sepsis. Full article
Show Figures

Figure 1

Back to TopTop